arotinolol has been researched along with Brain Vascular Disorders in 1 studies
arotinolol: structure given in first source; arotinolol is the (+-)-isomer
| Excerpt | Relevance | Reference |
|---|---|---|
| " At dosage levels similar to arotinolol, both pindolol and labetalol were less effective in preventing cerebral lesions despite lower blood pressure." | 1.28 | Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP. ( Hara, Y; Maniwa, T; Miyagishi, A; Noguchi, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyagishi, A | 1 |
| Maniwa, T | 1 |
| Noguchi, T | 1 |
| Hara, Y | 1 |
1 other study available for arotinolol and Brain Vascular Disorders
| Article | Year |
|---|---|
Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Cerebrovascular Disorders; Disease Susc | 1991 |